Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JR.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JR.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JG.3.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JG.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JG.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KE.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KE.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.86.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.86.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.86.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.86.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.26.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.26.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.26.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.26.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCPORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCPENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCPNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.6.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.6.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.6.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
EG.6.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
EG.5.1.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JF.1.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JF.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JF.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JF.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used